Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation

Midori Nakagaki; Elise Button; Amy Keating; Jodie Marsh; Chris Mitchell; Andrew Birchley; Glen A Kennedy

doi:10.1038/s41409-019-0586-1

Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation

Midori Nakagaki, Elise Button, Amy Keating, Jodie Marsh, Chris Mitchell, Andrew Birchley, Glen A Kennedy

Research output: Contribution to journal › Letter › peer-review

Abstract

High-dose melphalan (120–200 mg/m2) is widely used in preparative regimens for autologous and allogeneic haematopoietic stem cell transplantation (HSCT).

Original language	English
Pages (from-to)	827-829
Number of pages	3
Journal	BONE MARROW TRANSPLANTATION
Volume	55
Issue number	4
Early online date	11 Jun 2019
DOIs	https://doi.org/10.1038/s41409-019-0586-1
Publication status	Published - 1 Apr 2020
Externally published	Yes

Keywords

Hyperhydration
High-dose melphalan
Stem cell transplantation

Access to Document

10.1038/s41409-019-0586-1Licence: In Copyright

https://rdcu.be/dXeiMLicence: In Copyright

Cite this

@article{192f22c2ab11413889df2307ce5c35bd,

title = "Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation",

abstract = "High-dose melphalan (120–200 mg/m2) is widely used in preparative regimens for autologous and allogeneic haematopoietic stem cell transplantation (HSCT).",

keywords = "Hyperhydration, High-dose melphalan, Stem cell transplantation",

author = "Midori Nakagaki and Elise Button and Amy Keating and Jodie Marsh and Chris Mitchell and Andrew Birchley and Kennedy, {Glen A}",

year = "2020",

month = apr,

day = "1",

doi = "10.1038/s41409-019-0586-1",

language = "English",

volume = "55",

pages = "827--829",

journal = "BONE MARROW TRANSPLANTATION",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation

AU - Nakagaki, Midori

AU - Button, Elise

AU - Keating, Amy

AU - Marsh, Jodie

AU - Mitchell, Chris

AU - Birchley, Andrew

AU - Kennedy, Glen A

PY - 2020/4/1

Y1 - 2020/4/1

N2 - High-dose melphalan (120–200 mg/m2) is widely used in preparative regimens for autologous and allogeneic haematopoietic stem cell transplantation (HSCT).

AB - High-dose melphalan (120–200 mg/m2) is widely used in preparative regimens for autologous and allogeneic haematopoietic stem cell transplantation (HSCT).

KW - Hyperhydration

KW - High-dose melphalan

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=85067314697&partnerID=8YFLogxK

U2 - 10.1038/s41409-019-0586-1

DO - 10.1038/s41409-019-0586-1

M3 - Letter

C2 - 31186515

AN - SCOPUS:85067314697

SN - 0268-3369

VL - 55

SP - 827

EP - 829

JO - BONE MARROW TRANSPLANTATION

JF - BONE MARROW TRANSPLANTATION

IS - 4

ER -

Hyperhydration is not necessary for high-dose melphalan in stem cell transplantation

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this